Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 49
Filter
1.
Am J Respir Crit Care Med ; 198(7): 850-858, 2018 10 01.
Article in English | MEDLINE | ID: mdl-29746147

ABSTRACT

Female sex/gender is an undercharacterized variable in studies related to lung development and disease. Notwithstanding, many aspects of lung and sleep biology and pathobiology are impacted by female sex and female reproductive transitions. These may manifest as differential gene expression or peculiar organ development. Some conditions are more prevalent in women, such as asthma and insomnia, or, in the case of lymphangioleiomyomatosis, are seen almost exclusively in women. In other diseases, presentation differs, such as the higher frequency of exacerbations experienced by women with chronic obstructive pulmonary disease or greater cardiac morbidity among women with sleep-disordered breathing. Recent advances in -omics and behavioral science provide an opportunity to specifically address sex-based differences and explore research needs and opportunities that will elucidate biochemical pathways, thus enabling more targeted/personalized therapies. To explore the status of and opportunities for research in this area, the NHLBI, in partnership with the NIH Office of Research on Women's Health and the Office of Rare Diseases Research, convened a workshop of investigators in Bethesda, Maryland on September 18 and 19, 2017. At the workshop, the participants reviewed the current understanding of the biological, behavioral, and clinical implications of female sex and gender on lung and sleep health and disease, and formulated recommendations that address research gaps, with a view to achieving better health outcomes through more precise management of female patients with nonneoplastic lung disease. This report summarizes those discussions.


Subject(s)
Lung Diseases/epidemiology , Lung Diseases/physiopathology , Sleep Wake Disorders/epidemiology , Sleep Wake Disorders/physiopathology , Women's Health , Adult , Aged , Asthma/epidemiology , Asthma/physiopathology , Behavior , Comprehension , Disease Management , Education , Female , Humans , Middle Aged , National Heart, Lung, and Blood Institute (U.S.) , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/physiopathology , Risk Assessment , Severity of Illness Index , Sex Factors , Sleep Apnea Syndromes/epidemiology , Sleep Apnea Syndromes/physiopathology , United States
3.
Biol Sex Differ ; 7(Suppl 1): 44, 2016.
Article in English | MEDLINE | ID: mdl-27785346

ABSTRACT

In the era of individualized medicine, training future scientists and health-care providers in the principles of sex- and gender-based differences in health and disease is critical in order to optimize patient care. International successes to incorporate these concepts into medical curricula can provide a template for others to follow. Methodologies and resources are provided that can be adopted and adapted to specific needs of other institutions and learning situations.

4.
Clin Sci (Lond) ; 130(1): 1-7, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26586840

ABSTRACT

This article is intended to illuminate several important changes in our concept of gender-specific medicine in the genomic era. It reviews the history of gender-specific medicine, pointing out the changes in our perception of the nature of biological sex and our expanding knowledge of how it affects the phenotype. The old debate about 'nature versus nurture' is now largely resolved; the two are inextricably intertwined as a result of epigenomic regulation of gene expression; many of the resulting phenotypic changes are inherited and affect future generations. More accurate, rapid and cheaper methods of editing genomic composition are implementing a more sophisticated understanding of how genes function and how individual components of the genome might be added or eliminated to maintain health and prevent disease. As Venter predicted, the new discipline of synthetic biology, based on the creation and use of novel 'designer' chromosomes is an inevitable expansion of our ability to decipher the naturally occurring genome and the factors that control its expression. As we move with unexpected and stunning rapidity into our exploration and manipulation of the genetic code, our investigations must acknowledge the solidly established fact that biological sex will have a profound impact on the interventions we have made and will make in the future. Unfortunately, in spite of the recent urging of the National Institutes of Health (NIH) that sex be included as an essential variable in all levels of scientific investigation, genuine issues remain to be resolved before all scientists accept not only the importance of doing this, but also how to implement it.


Subject(s)
Genetic Markers , Genomics , Precision Medicine , Animals , Epigenesis, Genetic , Female , Gene Expression Regulation , Genetic Predisposition to Disease , Genomics/methods , Health Status Disparities , Humans , Male , Phenotype , Precision Medicine/methods , Sex Factors
5.
Clin Sci (Lond) ; 130(2): 125, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26669702
7.
Gend Med ; 8(5): 339-41, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21924962

Subject(s)
Metagenome , Humans , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...